🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, marketing, and customer laws, risking fines, legal action or prison.

Service Response and Content Elimination

According to TikTok, the service has removed problematic content and prohibited related keywords and search suggestions. The organization said it was committed to maintaining the service secure and investing in enhancing compliance measures.

Digital Trading Operations

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, filled with images of slimming results, positive reviews and detailed guides for mixing or administering at home.

After minutes of entering one group, a vendor shared contact information, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Item Details and Costs

Inside these groups, posts display dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they can’t verify. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has already encountered patients injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.